Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • OSI PHARMACEUTICALS INC Financial Overview

  • Income Statement: OSIP
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 379.39 M 172.27 M 207.11 M 54.59%
    Gross Profit 356.88 M 152.98 M 203.89 M 57.13%
    Net Income Before Extra Items/Preferred Div 471.48 M 66.32 M 405.17 M 85.93%
    Operating Income 137.31 M -60.94 M 198.25 M 144.38%
    View Full Report

  • Cash Flow: OSIP
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 92.48 M 24.76 M 67.73 M 73.23%
    Net Cash Flow - Investing 119.15 M -19.88 M 139.03 M 116.68%
    Net Cash Flow/Operating Activities 138.94 M 75.81 M 63.13 M 45.44%
    View Full Report

  • Balance Sheet: OSIP

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 801.85 M 558.38 M 243.47 M 30.36%
    Total Liabilities 230.31 M 419.42 M -189.12 M -82.11%
    Shareholders Equity 571.55 M 138.96 M 432.59 M 75.69%
    View Full Report

  • Key Ratios / Statistics: OSIP

    • Valuation

      Price/Earnings (TTM) 5.38
      Price/Sales (TTM) 6.89
      Price/Book (MRQ) 2.50
      Price/Cash Flow (TTM) 14.44

    • Profitability

      Gross Margin 94.07
      Operating Margin 36.19
      Profit Margin 124.28

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 10.10
      Current Ratio (MRQ) 13.45
      Long Term Debt-to-Equity (MRQ) 57.50

    • Management Effectiveness

      Return on Equity (TTM) 120.13
      Return on Assets (TTM) 59.93
      Return on Investments (TTM) 68.93
    View All Key Ratios